MedPath

EUPHRASIA COMPOSÉ

EUPHRASIA COMPOSÉ

Discontinued
DIN Number

02236431

Drug Class

Human

Market Date

Jan 5, 1998

Company
HC

dolisos canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02236431
AIG Number0618766002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormGlobules ,  Granules ,  Liquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

APIS MELLIFICAActive
Strength: 3 CH
Monograph: APIS MELLIFICA
EUPHRASIA OFFICINALISActive
Strength: 3 X
Monograph: EUPHRASIA OFFICINALIS
FORMICA RUFAActive
Strength: 3 CH
Monograph: FORMICA RUFA
MODIFIED RAGWEED TYROSINE ADSORBATEActive
Strength: 3 X
Monograph: MODIFIED RAGWEED TYROSINE ADSORBATE
ONIONActive
Strength: 3 X
Monograph: ONION
SABADILLAActive
Strength: 3 X
Monograph: SABADILLA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.